Patents Assigned to Sedac Therapeutics
  • Publication number: 20100324829
    Abstract: A method of selecting a test molecule that binds to HLA-DP4 by (i) incubating HLA-DP4 with the test molecule and a labeled peptide of formula (I) Z1X1X2X3X4X5X6X7X8X9Z2 thereby forming respective complexes, wherein Z1 and Z2, which may be identical or different, are each either zero or from 1 to 100 amino acids; X1 is an aromatic or hydrophobic amino acid, or S; X6 is an aromatic or hydrophobic amino acid, or C; X9 is an aromatic or hydrophobic amino acid, or C, D, Q, S, T, or E; and X2, X3, X4, X5, X7 and X8 are each an amino acid; (ii) separating the respective complexes formed; (iii) detecting the HLA-DP4/labeled peptide complexes; and (iv) selecting the test molecule that exhibits a binding activity of IC50<1000 nM, which corresponds to the concentration of the test molecule that inhibits 50% of the competitive HLA-DP4 binding of the labeled peptide.
    Type: Application
    Filed: March 8, 2010
    Publication date: December 23, 2010
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE, SEDAC THERAPEUTICS
    Inventors: Bernard MAILLERE, Florence Castelli, Cécile Buhot, Bertrand Georges
  • Patent number: 7718575
    Abstract: A method of selecting a test molecule that binds to HLA-DP4 by (i) incubating HLA-DP4 with the test molecule and a labeled peptide of formula (I) Z1X1X2X3X4X5X6X7X8X9Z2 thereby forming respective complexes, wherein Z1 and Z2, which may be identical or different, are each either zero or from 1 to 100 amino acids; X1 is an aromatic or hydrophobic amino acid, or S; X6 is an aromatic or hydrophobic amino acid, or C; X9 is an aromatic or hydrophobic amino acid, or C, D, Q, S, T, or E; and X2, X3, X4, X5, X7and X8 are each an amino acid; (ii) separating the respective complexes formed; (iii) detecting the HLA-DP4/labeled peptide complexes; and (iv) selecting the test molecule that exhibits a binding activity of IC50<1000 nM, which corresponds to the concentration of the test molecule that inhibits 50% of the competitive HLA-DP4 binding of the labeled peptide.
    Type: Grant
    Filed: October 17, 2002
    Date of Patent: May 18, 2010
    Assignees: Commissariat a l'Energie Atomique, Sedac Therapeutics
    Inventors: Bernard Maillere, Florence Castelli, Cécile Buhot, Bertrand Georges
  • Publication number: 20070243623
    Abstract: The invention relates to a device for the presentation of polypeptides, a method for the preparation and the use thereof, as diagnostic tool (polypeptide chip) for miniaturized and highly parallel detection of structurally or functionally complementary molecules of said polypeptides, i.e. antibodies.
    Type: Application
    Filed: May 15, 2003
    Publication date: October 18, 2007
    Applicants: Sedac Therapeutics, Centre National De La Recherche Scientifique, Universite De Lille 2
    Inventors: Oleg Melnyk, Xavier Duburcq, Helene Gras-Masse, Christophe Olivier, Fengling Zhou, Claude Auriault, Ahmed Bouzidi